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Abstract
Background: The exploitation of synthetic data in health care is at an early stage. Synthetic data could unlock the potential
within health care datasets that are too sensitive for release. Several synthetic data generators have been developed to date;
however, studies evaluating their efficacy and generalizability are scarce.
Objective: This work sets out to understand the difference in performance of supervised machine learning models trained on
synthetic data compared with those trained on real data.
Methods: A total of 19 open health datasets were selected for experimental work. Synthetic data were generated using three
synthetic data generators that apply classification and regression trees, parametric, and Bayesian network approaches. Real and
synthetic data were used (separately) to train five supervised machine learning models: stochastic gradient descent, decision tree,
k-nearest neighbors, random forest, and support vector machine. Models were tested only on real data to determine whether a
model developed by training on synthetic data can used to accurately classify new, real examples. The impact of statistical
disclosure control on model performance was also assessed.
Results: A total of 92% of models trained on synthetic data have lower accuracy than those trained on real data. Tree-based
models trained on synthetic data have deviations in accuracy from models trained on real data of 0.177 (18%) to 0.193 (19%),
while other models have lower deviations of 0.058 (6%) to 0.072 (7%). The winning classifier when trained and tested on real
data versus models trained on synthetic data and tested on real data is the same in 26% (5/19) of cases for classification and
regression tree and parametric synthetic data and in 21% (4/19) of cases for Bayesian network-generated synthetic data. Tree-based
models perform best with real data and are the winning classifier in 95% (18/19) of cases. This is not the case for models trained
on synthetic data. When tree-based models are not considered, the winning classifier for real and synthetic data is matched in
74% (14/19), 53% (10/19), and 68% (13/19) of cases for classification and regression tree, parametric, and Bayesian network
synthetic data, respectively. Statistical disclosure control methods did not have a notable impact on data utility.
Conclusions: The results of this study are promising with small decreases in accuracy observed in models trained with synthetic
data compared with models trained with real data, where both are tested on real data. Such deviations are expected and manageable.
Tree-based classifiers have some sensitivity to synthetic data, and the underlying cause requires further investigation. This study
highlights the potential of synthetic data and the need for further evaluation of their robustness. Synthetic data must ensure
individual privacy and data utility are preserved in order to instill confidence in health care departments when using such data to
inform policy decision-making.
(JMIR Med Inform 2020;8(7):e18910) doi: 10.2196/18910
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Introduction
Background
National health care departments hold volumes of data on
patients and the population, and this information is not being
used to its full potential due to valid privacy concerns. Machine
learning has the potential to improve decisions and outcomes
in health care, but these improvements have yet to be fully
realized. The reasons may be related to issues facing many data
scientists and researchers in this area: the limited availability
of or access to data or the readiness of health care institutions
to share data. Privacy concerns over personal data, and in
particular health care data, means that although the data exist,
they are deemed too sensitive for public release [1], even for
research purposes.
One way to overcome the issue of data availability is to use
fully synthetic data as an alternative to real data. The
exploitation of synthetic data in health care is at an early stage
and gaining attention. Synthetic data are simulated from real
data by using the underlying statistical properties of the real
data to produce synthetic datasets that exhibit these same
statistical properties. Synthetic data can represent the population
in the original data while avoiding any divulgence of real
personal, potentially confidential, and sensitive data. In the case
of health-related data, this would ensure that actual patient
records are not disclosed thus avoiding governance and
confidentiality issues. There are three types of synthetic data:
fully synthetic, partially synthetic, and hybrid synthetic. This
work considers fully synthetic data that does not contain original
data.
Synthetic data can be used in two ways: to augment an existing
dataset thus increasing its size, for times when a dataset is
unbalanced due to the limited occurrence of an event or when
more examples are required [2,3] and to generate a fully
synthetic dataset that is representative of the original dataset,
for times when data are not available due to their sensitive nature
[4]. The latter is considered in this work as a key requirement
for health care data sharing.
Traditionally, data perturbation techniques such as data
swapping, data masking, cell suppression, and adding noise
have been applied to real data to modify and thus protect the
data from disclosure prior to releasing it. However, such
methods do not eliminate disclosure risk and can impact the
utility of the data, particularly if multivariate relationships are
not considered [5]. Synthetic data was first proposed by Rubin
[6] and Little [7]. Raghunathan et al [8] implemented and
extended upon this, pioneering the multiple imputation approach
to synthetic data generation, exemplified in a range of studies
[9-14]. Reiter [15] then introduced an alternative method of
synthesizing data through a nonparametric tree–based technique
that uses classification and regression trees (CART). A more
recent technique proposes a Bayesian network approach for
synthetic data generation [16]. Synthetic data is considered a
secure approach for enabling public release of sensitive data as
it goes beyond traditional deidentification methods by generating
a fake dataset that does not contain any of the original,
identifiable information from which it was generated, while
retaining the valid statistical properties of the real data.
Therefore, the risk of reverse engineering or disclosure of a real
person is considered to be unlikely [17].
While a number of synthetic data generators have been
developed, empirical evidence of their efficacy has not been
fully explored. This work extends a preliminary study [18] and
investigates whether fully synthetic data can preserve the hidden
complex patterns supervised machine learning can uncover from
real data and therefore whether it can be used as a valid
alternative to real data when developing eHealth apps and health
care policy making solutions. This will be achieved by
experimenting with a range of open health care datasets.
Synthetic data will be generated using three well-known
synthetic data generation techniques. Supervised machine
learning algorithms will be used to validate the performance of
the synthetic datasets. Statistical disclosure control (SDC)
methods that can further decrease the disclosure risk associated
with synthetic data will also be considered.
Overview
To inform the viability of the use of synthetic data as a valid
and reliable alternative to real data in the health care domain,
we will answer the following research questions:
• What is the differential in performance when using synthetic
data versus real data for training and testing supervised
machine learning models?
• What is the variance of absolute difference of accuracies
between machine learning models training on real and
synthetic datasets?
• How often does the winning machine learning technique
change when training using real data to training using
synthetic data?
• What is the impact of SDC (ie, privacy protection) measures
on the utility of synthetic data (ie, similarity to real data)?
To answer these questions, 19 open health care datasets
containing both categorical and numerical data were selected
for experimentation [19]. Synthetic datasets were generated for
each dataset using three popular synthetic data generators that
apply CART [15,17], parametric [8,17], and Bayesian network
[16] approaches to enable a robust comparison of the three
synthetic data generation techniques across a broad range of
data.
Initially, we analyzed whether the multivariate relationships
that exist in the real data were preserved in the synthetic versions
of the data for data generated using each of the three synthetic
data generation techniques by computing pairwise mutual
information scores for each variable pair combination in each
dataset [16]. It is important that such relationships are retained
when data are synthesized.
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To evaluate the utility of synthetic data for machine learning,
we then investigated the performance of supervised machine
learning models trained on synthetic data and tested on real data
compared with models trained on real data and also tested on
the real data. This allowed us to determine if a model developed
using synthetic data can classify real data examples as accurately
and reliably as a model developed using real data. We
considered five supervised machine learning models to compare
performance and determine if there were differences in
robustness across the models. Standard evaluation metrics were
computed for models trained on real and synthetic data, for each
machine learning model, and for each dataset [20]. The
differences in accuracy for models trained on synthetic data
versus models trained on real data were computed to analyze
the extent to which synthetic data causes a degradation in model
performance, if any.
It is pertinent that the optimal machine learning model built
using synthetic data matches the optimal machine learning
model that would be selected if real data were used in the model
training process. This would provide stakeholders in health care
with confidence in the use of synthetic data for model
development. Thus, we considered how often the best machine
learning classifier built using synthetic data matches the best
machine learning model built using real data.
Finally, the impact of a number of SDC methods on model
performance was assessed. SDC methods seek to further enhance
data privacy; however, this can lead to a loss in usefulness of
the data [21], and we considered the extent to which
performance degradation occurs as a result of SDC.
This large-scale assessment of the reliability of synthetic data
when used for supervised machine learning using 19 health care
datasets and 3 synthetic data generation techniques provides an
important contribution in relation to the trust and confidence
that stakeholders in health care can have in synthetic data. We
also propose a pipeline to illustrate how synthetic data can
potentially fit within the health care provider context. This work
demonstrates the promising performance of synthetic data while
highlighting its limitations and future work directions to
overcome them.
Synthetic Data: Present and Future Use
The validity and disclosure risk associated with synthetic data
has been under investigation by the US Census Bureau since
2003 for the purpose of creating public use data from a
combination of sensitive data from the Census Bureau’s Survey
of Income and Program Participation, the Internal Revenue
Service’s individual lifetime earnings data, and the Social
Security Administration’s individual benefit data [22,23]. The
goal was to enable the release of synthesized person-level
records containing personal and financial characteristics from
confidential datasets while preserving privacy. Successful results
have led to the release of public use synthetic data files.
Researchers can have their work validated against the gold
standard (real) data by the Census Bureau, thus enabling them
to determine the impact of synthetic data on their exploratory
analyses and model development and have confidence in their
results while also allowing the Census Bureau to continuously
improve their synthesis techniques. The public release of this
data has provided significant benefit to the research community
and general population, enabling more extensive economic
policy research to be performed by groups who could not
previously access useful data [24-29]. This work led to the
release of further synthetic datasets by the Census Bureau. The
Synthetic Longitudinal Business Database comprises data from
an annual economic census of establishments in the United
States [30]. This dataset provides broad access to rich data that
supports the research and policy-making communities in
business- and employment-related topics. OnTheMap is a tool
using synthetic data to provide information on US citizens such
as workforce-related maps, demographic profiles, and reports
on analyses of information including the location and
characteristics of workers living or working in selected areas,
the distance and direction totals between residence and
employment locations for workers in selected areas, and disaster
event information and the impact of such events on workers
and employers [31]. Similarly, synthetic data has also been
under investigation in the United Kingdom as a means to provide
public access to rich data from UK longitudinal studies [32-34]
that contain highly sensitive data linking national census data
to administrative data for individuals and their families.
These datasets enable researchers to explore data and develop
and test code and models outside the secure environment where
real data reside with no restrictions while the data owners
provide a mechanism where results, code, and models can be
validated on behalf of researchers on the real data within the
secure environment and feedback provided. This process
increases research productivity while ensuring the development
of robust and valid models [35].
While synthetic data have been used to accelerate and
democratize business and economic policy research [22-35],
the process is not currently in use for health care research, an
area that could benefit enormously. With advancements in
technology, particularly machine learning and artificial
intelligence (AI), the potential to develop diagnostic tools for
clinicians and data driven decision-making platforms for health
policy-makers is ever increasing [36,37]. Such tools require
access to health care data, for example, to train AI algorithms
and produce models that can identify health conditions and
health-related patterns across the population. Currently, it can
take a lengthy period of time for researchers to gain access to
health care data, a rich and underused resource, due to privacy
concerns [38-42]. For example, in the case of the 40-month
Meaningful Integration of Data, Analytics, and Services
(MIDAS) Project [36,43] developing a data-driven
decision-making tool for health care policy makers, it took more
than 20 months to obtain access to the required data due to legal
and ethical constraints. In addition, a number of important data
variables could not made available, which restricted the utility
of the platform under development. With the help of synthetic
data, such data, with more or all variables included, could have
been made available in a matter of weeks, thus providing more
time for development and evaluation of the platform. The
platform could then have been installed in health care sites more
quickly and connected to real data for validation and comparison
of performance for synthetic versus real data, enabling
performance tweaks to mitigate bias introduced by synthetic
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data, if any. Synthetic data could also enable cross-site analytics
in various health regions that would enable policy makers to
connect their health spaces and potentially provide significant
enhancements to cross-national health policy.
The ultimate goal of this work was to further assess the validity
and disclosure risk of synthetic data under the stringent
conditions associated with health care data with the view to
successfully developing a pipeline for use in health care that
enables synthetic datasets to be released publicly to researchers,
who would otherwise not be able to access the data or access it
in a timely fashion, in order to accelerate research by enabling
the wider research community to use the data for analysis and
model development. The results of such analyses and the models
and code developed can then be given to health care departments
for validation on the real data and, if effective, put into use by
clinicians and health policy-makers.
Synthetic Data Pipeline for Health Care
To understand how health care departments can benefit from
synthetic data, we propose the pipeline shown in Figure 1. This
is a proposed synthetic data-sharing pipeline provided as an
illustration of how synthetic data can potentially work within
a real health care setting to expedite data analytics. In future
work, we plan to test this pipeline in a real setting. In this
pipeline, real data reside within the national health care
department infrastructure. The data cannot be shared externally
due to the sensitive and private nature. Health care departments
may only have a small number of data science staff with the
expertise necessary to apply machine learning techniques to
many of their datasets, so they cannot maximize the use of their
data or discover the potential use of the data due to lack of
resources. By applying a synthetic data generation technique
to the real data along with SDC measures, a synthetic dataset
can be produced and made available to the external research
community in place of the real data. External researchers, in
large numbers and with wide-ranging expertise, can potentially
develop optimal machine learning models trained on the
synthetic data and share the performance of the machine learning
model, the model itself, and the model specification with the
national health care department. The health care department
can then test the machine learning model on real data, or
in-house technical staff can rebuild the model according to the
specification provided by researchers including the program
code written by researchers, details of the machine learning
algorithm to use (eg, decision tree [DT], support vector machine
[SVM]), and the optimal hyperparameter settings determined
during development. Using these settings, the model can be
rebuilt, this time by training on the real data instead of synthetic
data, to which in-house staff have access.
Figure 1. Proposed synthetic data sharing pipeline illustrates how synthetic data could be implemented to expedite health care data analytics.
Methods
Dataset Selection
For experimentation, 19 open health care datasets have been
selected from the University of California Irvine Machine
Learning Repository [19]. Missing values have been removed
from the datasets either by removing features with a high
number of missing values or removing observations where a
feature contains a missing value. The experimental datasets and
their properties are summarized in Table 1. These datasets were
selected to enable an analysis of synthetic data performance
when applied to datasets of differing volume and data types
(categorical and numerical).
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Table 1. Summary of experimental datasets.
Observations nClasses/labels nNumerical attributes nCategorical attributes nAttributes nDataset and letter designationa




















aEach dataset has been encoded with a letter (column 1) and will be referenced using this letter for the remainder of the paper.
bEEG: electroencephalograph.
Generating Synthetic Data
In this work, we analyzed and assessed the performance of three
publicly available synthetic data generation techniques that are
based on well known, seminal work in the area [6-10,15,16]: a
parametric data synthesis technique, a nonparametric tree-based
synthesis technique that uses CART [15], and a synthesis
technique that uses Bayesian networks [16]. While other
approaches exist, some are developed for specific datasets and
problems (eg, SimPop simulates population survey data [44],
and Synthea simulates patient population and electronic health
record data [45]), whereas these techniques are considered to
be more general. The R package Synthpop, developed by Nowak
et al [17], provides a publicly available implementation of the
parametric- and CART-based synthetic data generators. The
DataSynthesizer python implementation, developed by Ping et
al [16], provides a publicly available implementation of the
Bayesian network-based synthetic data generator. These
implementations have been used in this experimental work.
Attributes were synthesized sequentially in both the parametric
and CART methods. The synthetic values for the first attribute
were synthesized using a random sample from the original
observed data since it has no predictors from previously
synthesized attributes in the dataset. When synthesizing
attributes, both categorical and numerical, with the
nonparametric method, the CART method was applied. CART
was applied to all variables that had predictors (ie, attributes
prior to them in the sequence) and drew from the conditional
distributions fitted to the original data using CART models. The
parametric method synthesizes attributes based on data type.
Numerical attributes were synthesized using normal linear
regression. Categorical attributes were synthesized using
polytomous logistic regression where the attribute had more
than two levels, and logistic regression was applied to synthesize
binary categorical variables [17]. The Bayesian network method
of synthesizing data learned a differentially private Bayesian
network that captured correlation structure between attributes
in the real data and drew samples from this model to produce
synthetic data [16].
Supervised Machine Learning With Real and Synthetic
Data
A key measure of data utility of a synthetic dataset for the
purpose of machine learning is to determine how well a
supervised machine learning model trained on synthetic data
performs when tasked with classifying real data. This determines
whether supervised machine learning models will be robust
enough to classify real data examples if only synthetic data are
provided for the training of these models.
To evaluate whether synthetic datasets could be used as a valid
alternative to real datasets in machine learning, for each of the
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19 datasets (Table 1), five classification models were trained.
Initially, the models were trained and tested on the real data to
obtain a performance benchmark. Subsequently, a classifier was
trained on each of the synthetic datasets, generated using
parametric, CART and Bayesian network techniques, and then
tested with the real data. Models were tested on real data only
to determine whether a model developed by training on synthetic
data can be put into use by health care departments and used to
accurately classify new, real examples.
The range of models applied to each dataset were stochastic
gradient descent DT, k-nearest neighbors (KNN), random forest
(RF), and SVM. This selection of algorithms was applied to
determine how well each performed when trained with the real
data compared with the synthetic data, with both tested on real
data.
The classifiers were implemented using Python’s Scikit-Learn
0.21.3 machine learning library and are as follows:
• Stochastic gradient descent classification was implemented
using SGDClassifier, a simple linear classifier, with
loss=“hinge,” random_state=0 and all other parameters set
to their defaults
• DT classification was implemented using
DecisionTreeClassifier, an optimized version of CART,
with criterion=“gini,” max_depth=10, and random_state=0
and all other parameters set to their defaults
• K-nearest neighbors classification was implemented using
KNeighborsClassifier with n_neighbors=10,
weights=“uniform,” leaf_size=30, p=2,
metric=“minkowski,” n_jobs=2 and all other parameters
set to their defaults
• RF classification was implemented using
RandomForestClassifier with criterion=“gini,”
max_depth=10, min_samples_split=2, n_estimators=10,
random_state=1 and all other parameters set to their defaults
• SVM classification was implemented using SVC with
C=1.0, degree=3, kernel=“rbf,” probability=True,
random_state=None and all other parameters set to their
defaults
For training and testing, Python’s Scikit-Learn 0.21.3
ShuffleSplit random permutation cross-validator was used with
10 splitting iterations and a train/test split of 75/25. Categorical
attributes were transformed into indicator attributes using
one-hot encoding.
Statistical Disclosure Control
Synthetic data are considered not to contain real units and
therefore the risk of disclosure of a real person is considered to
be unlikely [46]. While unlikely, the scenario where some of
the generated synthetic data are very similar to the real data
resulting in potential disclosure risk must be considered, and
where additional protections can be applied to synthetic data,
it is recommended to do so. Additional SDC measures beyond
data synthesis can be applied as a precautionary measure to add
further protections to synthetic data by reducing the risk of
reproducing real-person records and replicating outlier data,
thus further minimizing the risk of disclosure. There are two
broad categories of SDC; rules-based SDC consists of a set of
fixed rules governing what data can or cannot be released (eg,
a rule setting a specific minimum frequency threshold on a
dataset in order for it to be released) and principles-based SDC
consists of a broader assessment of risk for a dataset to
determine whether it is safe for release (eg, in the case where a
specific rule on thresholds may not be applicable because the
data cannot be linked back to individuals or in cases where
thresholds are not enough to protect individuals from
reidentification [47]). SDC measures can be applied, evaluated,
and reparameterized as part of the penetration and
reidentification testing that health care providers would apply
before releasing a synthesized dataset.
The following SDC methods, appropriate for rules-based SDC,
have been considered and applied in experimental work to
determine their effect on data utility:
• Minimum leaf size (CART method specific): for the CART
method, a minimum final leaf node size can be set to avoid
the risk of final nodes containing small numbers of records,
thus increasing the risk of producing real records (and thus
real-person data) in the synthesized data. In SDC
experiments, this is set to 10.
• Smoothing: smoothing can be applied to
continuous/numerical fields in the synthesized data to
reduce the risk of releasing unusual/outlier data. In SDC
experiments, gaussian kernel density smoothing is applied
to numerical attributes only.
• Unique removal: unique records with variable sequences
that are identical to records in the real dataset can be
removed. In SDC experiments, this has been applied to
synthetic data.
Each of these SDC techniques have been applied to the datasets
generated using the CART technique, and the smoothing and
unique removal techniques have been applied to datasets
generated using the parametric technique. SDC methods have




Comparison of Variable Relationships
Within a dataset, relationships can exist between variables.
When data are synthesized, we wish to determine whether these
relationships are preserved and where they are not preserved,
whether this relates to the synthesis technique or structure of
the dataset. An analysis of these linear relationships was
performed by computing the normalized pairwise mutual
information score between each pair of attributes. This is a
measure of association or similarity where a higher score
indicates a greater association between two attributes. Figure 2
provides a visual representation of the normalized pairwise
mutual information scores in adjacency heatmaps for each of
the 19 datasets (listed in column 1) and enables visual
determination of whether the associations found in the real
datasets (column 2) are similar to the associations in the
synthetic datasets (columns 3-5) for each of the three synthetic
data generators.
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Figure 2. Pairwise mutual information for the real and synthetic datasets. These adjacency heat maps provide an efficient approach to visually determine
whether the associations in the real datasets are similar to the associations in the corresponding synthetic datasets. Column 1 indicates the dataset,
columns 2 indicates the pairwise mutual information for the real data, and columns 3-5 indicate the pairwise mutual information for synthetic datasets
generated using CART, parametric and Bayesian network approaches, respectively.
The relationships between variables changed slightly in synthetic
data generated using the CART and parametric techniques for
datasets C-G, I-K, and S, with decreased correlations observed
between attribute pairs. These datasets contain mainly and in
some cases only numerical attributes. The relationships were
largely preserved for the other datasets, which contain mainly
and in some cases only categorical attributes, with the exception
of dataset A, which contains only numerical attributes.
The relationships between variables also changed slightly in a
number of datasets synthesized using the Bayesian network
technique (eg, E-G, I-L, N, P-S), with increased correlations
observed between attribute pairs. The relationships were largely
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preserved in datasets B-D, M, and O, while a slight decrease in
correlations between attribute pairs was observed for datasets
A and H. In this case, the changes cannot be attributed to a
particular data type.
Supervised Machine Learning With Real and Synthetic
Data
Performance Comparison
To compare the performance of each model when trained on
the synthetic data and tested with the real data, a variety of
evaluation metrics were used. The accuracy, precision, recall,
and F1 score were computed to determine performance.
The accuracy scores for five machine learning models are shown
in Table 2 for datasets A through S. Accuracy scores for models
trained on the real data and synthetic data are shown where
synthetic data is generated using CART, parametric, and
Bayesian network techniques, respectively. The accuracy of the
models when trained on synthetic data is lower than the accuracy
when trained on real data in 92% (263/285) of cases (ie, machine
learning results are less accurate for synthetic data in 92% of
cases; Table 3).
Although the accuracy decreases in most cases when using
synthetic models, this reduction in accuracy is small. The mean
absolute difference in accuracy in models trained with synthetic
data across all three synthesizing techniques is lowest for SVM,
SGD, and KNN models at 0.058 (6%), 0.064 (6%), and 0.072
(7%), respectively. RF and DT models have larger deviations
in accuracy at 0.177 (18%) and 0.193 (19%), respectively (Table
4). This pattern is also consistent when considering results for
each of the three synthetic data generators separately. These
results are illustrated in the boxplots in Figure 3. The mean
absolute difference may provide a reliable indicator of the
expected decrease in accuracy in supervised machine learning
models when developed using synthetic data. A small yet
consistent difference in accuracy is expected and manageable
between real and synthetic data.
In addition to accuracy scores, we consider changes to precision,
recall, and F1 scores. Precision, recall, and F1 scores decrease
in almost all models and for data generated with each synthetic
data technique across all 19 datasets (Figure 4). These decreases
indicate that the models generated with synthetic data have a
higher rate of false-positive and false-negative predictions than
models trained with real data. Decreases in precision, recall,
and F1 are larger in DT and RF models, consistent with changes
in accuracy scores; however, the changes are larger than changes
in accuracy for these models. The variance in precision, recall,
and F1 differences are also more notable in models trained with
synthetic data generated using the Bayesian network approach
with less problematic decreases observed in models trained with
synthetic data generated using the CART and parametric
approaches.
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Table 2. Comparison of accuracy scores of five supervised machine learning models trained on real data and synthetic data across 19 datasets. Increase
or decrease in accuracy compared with the model trained on real data shown in parentheses.
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0.536 (–0.124)0.706 (W) (–0.254)0.542 (–0.184)0.664 (–0.336)0.502 (–0.130)CART
0.545 (–0.115)0.628 (–0.334)0.508 (–0.218)0.666 (W) (–0.334)0.472 (–0.160)Parametric
0.557 (–0.103)0.649 (W) (–0.313)0.511 (–0.215)0.592 (–0.408)0.438 (–0.194)Bayesian
E
0.9951.000 (W)0.9811.000 (W)0.995Real
0.994 (–0.001)0.995 (W) (–0.005)0.967 (–0.014)0.944 (–0.056)0.972 (–0.023)CART
0.988 (W) (–0.007)0.988 (W) (–0.012)0.965 (–0.016)0.981 (–0.019)0.964 (–0.031)Parametric
0.993 (W) (–0.002)0.992 (–0.008)0.974 (–0.007)0.957 (–0.043)0.986 (–0.009)Bayesian
F
0.9130.9820.9120.985 (W)0.89Real
0.889 (–0.024)0.921 (–0.061)0.883 (–0.029)0.922 (W) (–0.063)0.869 (–0.021)CART
0.894 (–0.019)0.914 (W) (–0.068)0.886 (–0.026)0.907 (–0.078)0.873 (–0.017)Parametric
0.893 (–0.020)0.924 (W) (–0.058)0.885 (–0.027)0.918 (–0.067)0.880 (–0.010)Bayesian
G
0.820.971 (W)0.780.9590.746Real
0.748 (–0.072)0.841 (–0.070)0.678 (–0.102)0.848 (W) (–0.111)0.667 (–0.079)CART
0.737 (–0.083)0.801 (–0.107)0.676 (–0.104)0.805 (W) (–0.154)0.669 (–0.077)Parametric
0.739 (–0.081)0.822 (–0.149)0.676 (–0.104)0.835 (W) (–0.124)0.676 (–0.070)Bayesian
H
0.9920.9940.980.9971.000 (W)Real
0.955 (–0.037)0.958 (W) (–0.036)0.891 (–0.089)0.941 (–0.056)0.940 (–0.060)CART
0.959 (W) (–0.032)0.959 (W) (–0.135)0.898 (–0.082)0.951 (–0.046)0.935 (–0.065)Parametric
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Machine learning algorithm accuracyDataset and training seta
SVMfRFeKNNdDTcSGDb
0.959 (W) (–0.032)0.955 (–0.139)0.899 (–0.081)0.952 (–0.045)0.940 (–0.060)Bayesian
I
0.6760.896 (W)0.7110.8450.706Real
0.609 (–0.067)0.671 (W) (–0.225)0.634 (–0.077)0.643 (–0.202)0.594 (–0.112)CART
0.608 (–0.068)0.663 (W) (–0.233)0.624 (–0.087)0.638 (–0.207)0.570 (–0.136)Parametric
0.622 (–0.054)0.667 (W) (–0.229)0.629 (–0.082)0.648 (–0.197)0.609 (–0.097)Bayesian
J
0.6510.981 (W)0.6420.981 (W)0.453Real
0.551 (–0.100)0.649 (–0.332)0.579 (–0.063)0.655 (W) (–0.326)0.526 (+0.073)CART
0.549 (–0.102)0.628 (–0.354)0.606 (–0.036)0.689 (W) (–0.292)0.555 (+0.102)Parametric
0.551 (–0.100)0.602 (W) (–0.379)0.585 (–0.057)0.585 (–0.396)0.545 (+0.092)Bayesian
K
0.5510.885 (W)0.8640.8450.551Real
0.531 (W) (–0.020)0.512 (–0.373)0.531 (W) (–0.333)0.531 (W) (–0.314)0.510 (–0.041)CART
0.531 (–0.020)0.519 (–0.366)0.510 (–0.354)0.545 (W) (–0.300)0.514 (–0.037)Parametric
0.510 (–0.041)0.531 (–0.354)0.510 (–0.354)0.538 (W) (–0.307)0.490 (–0.061)Bayesian
L
0.8650.9770.8611.000 (W)0.851Real
0.785 (–0.080)0.803 (W) (–0.174)0.758 (–0.103)0.781 (–0.219)0.791 (–0.060)CART
0.793 (–0.072)0.809 (–0.168)0.786 (–0.075)0.758 (–0.242)0.822 (W) (–0.029)Parametric
0.834 (W) (–0.031)0.799 (–0.178)0.818 (–0.043)0.738 (–0.262)0.785 (–0.066)Bayesian
M
0.9390.9860.8381.000 (W)0.899Real
0.782 (W) (–0.157)0.780 (–0.206)0.762 (–0.076)0.762 (–0.238)0.726 (–0.173)CART
0.796 (W) (–0.143)0.772 (–0.214)0.757 (–0.081)0.765 (–0.235)0.739 (–0.160)Parametric
0.780 (W) (–0.159)0.746 (–0.240)0.703 (–0.135)0.662 (–0.338)0.681 (–0.218)Bayesian
N
0.7130.908 (W)0.7130.908 (W)0.713Real
0.720(W) (+0.007)0.680 (–0.228)0.715 (+0.002)0.667 (–0.241)0.706 (–0.007)CART
0.708 (W) (–0.005)0.646 (–0.262)0.706 (–0.007)0.614 (–0.294)0.644 (–0.067)Parametric
0.694 (–0.019)0.630 (–0.278)0.706 (W) (–0.007)0.591 (–0.317)0.559 (–0.154)Bayesian
O
0.560.762 (W)0.4580.7320.449Real
0.425 (W) (–0.135)0.410 (–0.352)0.411 (–0.047)0.401 (–0.331)0.338 (–0.111)CART
0.433 (W) (–0.127)0.397 (–0.365)0.413 (–0.045)0.377 (–0.355)0.317 (–0.192)Parametric
0.419 (W) (–0.141)0.361 (–0.401)0.375 (–0.083)0.336 (–0.396)0.293 (–0.156)Bayesian
P
0.9810.9820.9810.985 (W)0.981Real
0.981 (W) (0.000)0.981 (W) (–0.001)0.981 (W) (0.000)0.977 (–0.008)0.981 (W) (0.000)CART
0.981 (W) (0.000)0.981 (W) (–0.001)0.981 (W) (0.000)0.976 (–0.009)0.981 (W) (0.000)Parametric
0.981 (W) (0.000)0.981 (W) (–0.001)0.981 (W) (0.000)0.977 (–0.008)0.981 (W) (0.000)Bayesian
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0.851 (W) (0.000)0.835 (–0.093)0.850 (–0.003)0.795 (–0.137)0.834 (–0.006)CART
0.849 (W) (–0.002)0.838 (–0.090)0.848 (–0.005)0.811 (–0.121)0.798 (–0.042)Parametric
0.851 (W) (0.000)0.837 (–0.091)0.846 (–0.007)0.794 (–0.138)0.823 (–0.017)Bayesian
R
0.7380.9610.7950.989 (W)0.755Real
0.733 (–0.005)0.825 (W) (–0.136)0.761 (–0.034)0.819 (–0.170)0.742 (–0.013)CART
0.734 (–0.004)0.798 (W) (–0.163)0.764 (–0.031)0.786 (–0.203)0.749 (–0.006)Parametric
0.734 (–0.004)0.832 (–0.129)0.762 (–0.033)0.835 (W) (–0.154)0.748 (–0.007)Bayesian
S
0.9531.000 (W)0.9211.000 (W)0.958Real
0.913 (–0.040)0.935 (W) (–0.065)0.899 (–0.022)0.901 (–0.099)0.903 (–0.055)CART
0.926 (–0.027)0.930 (W) (–0.060)0.912 (–0.009)0.913 (–0.087)0.890 (–0.068)Parametric
0.930 (–0.023)0.936 (W) (–0.064)0.908 (–0.013)0.914 (–0.086)0.905 (–0.053)Bayesian
aTraining dataset name indicates if real or synthetic data were used to train the model and for synthetic datasets which synthetic data generator was used
(ie, CART, parametric, or Bayesian).




fSVM: support vector machine.
g(W) highlights the winning classifier for each training set.
hCART: classification and regression trees.
Table 3. Changes in accuracy for each machine learning model and synthetic data type (19 datasets and 3 synthetic data generators considered providing
57 synthetic datasets to analyze).





RFd (n=57), n (%)KNNc (n=57), n (%)DTb (n=57), n
(%)
SGDa (n=57), n (%)
11 (4)1 (2)0 (0)2 (4)0 (0)8 (14)Increase
11 (4)5 (9)0 (0)3 (5)0 (0)3 (5)Same
263 (92)51 (89)57 (100)52 (91)57 (100)46 (81)Decrease




eSVM: support vector machine.
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Table 4. Mean absolute difference in accuracy for each machine learning model and synthetic data type.
Mean absolute difference in accuracy per machine learning algorithmSynthetic dataset
SVMe, n (%)RFd, n (%)KNNc, n (%)DTb, n (%)SGDa, n (%)
0.058 (5.8)0.164 (16.4)0.069 (6.9)0.186 (18.6)0.053 (5.3)CARTf
0.060 (6.0)0.183 (18.3)0.072 (7.2)0.189 (18.9)0.071 (7.1)Parametric
0.056 (5.6)0.183 (18.3)0.075 (7.5)0.204 (20.4)0.069 (6.9)Bayesian network
0.058 (5.8)0.177 (17.7)0.072 (7.2)0.193 (19.3)0.064 (6.4)ALL




eSVM: support vector machine.
fCART: classification and regression trees.
Figure 3. Overall change in accuracy for each machine learning model when trained on synthetic data across 19 datasets and 3 synthetic data approaches
where classification and regression tree (a), parametric (b), Bayesian network (c), and all approaches combined (d), compared with models trained using
real data.
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Figure 4. Overall change in precision (a-c), recall (d-f), and F1 (g-i) scores for each machine learning model when trained on synthetic data (from 19
datasets) generated using classification and regression tree (a, d, g), parametric (b, e, h) and Bayesian network (c, f, i) approaches, compared with models
trained using real data.
Winning Classifier
In the pipeline described previously, health care departments
may wish to release synthetic versions of data to the wider
research community for the development of an optimal machine
learning model—for example, they may wish to determine the
best classifier to use on their real data by making use of the
wider range of expertise and scale the external research
community can provide. The researchers would be expected to
train and test various models and hyperparameters to find the
best solution. The researchers would then return a model and/or
model specification to the health departments, enabling them
to test the model on real data and/or enabling a health
department’s technical staff to recreate a version of the model,
this time trained on the real data to which in-house staff have
access. Health departments would have the expectation that this
would be the same model determined if real data had been used
to develop the best model (ie, it would have been the “winning”
model when trained on either synthetic or real data).
We compared the winning classifier when trained and tested on
real data with the winning classifier when trained on synthetic
data and tested on real data. Table 2 lists the winning classifier
(marked as W on each row) for each dataset when trained with
real and synthetic data and when tested on the real data.
The winning classifier when trained on real data matches the
winning classifier when trained on synthetic data in only 26%
(5/19) of cases for synthetic data generated using the CART
and parametric methods, and in just 21% (4/19) of cases on data
synthesized using the Bayesian network technique (Table 5).
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Table 5. Number of instances where the winning classifier trained on synthetic data matches the winning classifier trained on real data across 19
datasets.
Winning classifier matches for real versus syntheticSynthetic dataset
3 classifiers (DT and RFb removed)4 classifiers (DTa removed)5 classifiers
14/19 (73.7)10/19 (52.6)5/19 (26.3)CARTc
10/19 (52.6)10/19 (52.6)5/19 (26.3)Parametric




cCART: classification and regression trees.
The DT classifier is most often the winning classifier, in 14/19
datasets, when real data are used to train and test the model, but
DT is not the best classifier on synthetic data, winning in only
11/57 cases (Table 2). Tree-based methods (DT and RF) are the
winning classifier on real data in 18/19 cases (95%). If we
remove DTs from this analysis, the cases where the winning
classifier when trained on synthetic data matches the winning
classifier when trained on real data almost doubles, increasing
to 53% (10/19) of cases for synthetic data generated using each
of the three synthesizing techniques (Table 5).
With DTs removed, RF models are now the most frequent
winners (18/19) when real data are used to train and test the
model. In this case, RF models produce the winning classifier
in 32/57 cases (Table 2). If we further remove RFs from this
analysis and do not consider tree-based classifiers, cases where
the winning classifier when trained on synthetic data matches
the winning classifier when trained on real data increases from
53% to 74% (14/19) and 68% (13/19) for data synthesized using
CART and Bayesian network techniques, respectively, and
remains unchanged for data generated using the parametric
technique (Table 5).
A chi-square test is applied with the following null and
alternative hypotheses:
• H0: the number of winning classifier matches is equal across
all sets of classifiers.
• H1: the number of winning classifier matches increases
when DT and RF classifiers are removed.
The level of significance adopted for hypothesis testing is .05
for all tests performed.
The null hypothesis is rejected when the tree-based models (DTs
and RFs) are removed (ie, from 5 to 3 classifiers) for data
synthesized using the CART and Bayesian network methods
(Table 6). Therefore, a significant difference in the matching
winning classifiers is observed when tree-based classifiers are
removed for these two synthesizing techniques. The null
hypothesis could not be rejected in all other cases.
Table 6. Results of chi-square analysis of the difference in matching winning classifiers for models trained on real versus synthetic data.
Winning classifier matches for real versus syntheticSynthetic dataset






cCART: classification ans regression trees.
Impact of Statistical Disclosure Control
The impact of SDC methods on data utility is considered across
all datasets. Table 7 illustrates the effect on model accuracy of
applying smoothing (numeric attributes only), removal of unique
records, and limiting the minimum leaf size (CART models
only) to all synthetic datasets where each method is applicable.
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Table 7. Changes in accuracy for each machine learning model and with statistical disclosure control applied.
Machine learning algorithm change in accuracy with SDCaChange in accuracy
TotalSVMfRFeKNNdDTcSGDb
Smoothing (n=150)
7/150 (4.7)2/30 (6.7)0/30 (0.0)1/30 (3.3)0/30 (0.0)4/30 (13.3)Increase
7/150 (4.7)3/30 (10.0)0/30 (0.0)2/30 (6.7)0/30 (0.0)2/30 (6.7)Same
136/150 (90.7)25/30 (83.3)30/30 (100.0)27/30 (90.0)30/30 (100.0)24/30 (80.0)Decrease
Unique removal (n=190)
7/190 (3.7)2/38 (5.3)0/38 (0.0)1/38 (2.6)0/38 (0.0)4/38 (10.5)Increase
8/190 (4.2)4/38 (10.5)0/38 (0.0)2/38 (5.3)0/38 (0.0)2/38 (5.3)Same
175/190 (92.1)32/38 (84.2)38/38 (100.0)35/38 (92.1)38/38 (100.0)32/38 (84.2)Decrease
Minimum leaf size (n=95)
3/95 (3.2)1/19 (5.3)0/19 (0.0)0/19 (0.0)0/19 (0.0)2/19 (10.5)Increase
4/95 (4.2)2/19 (10.5)0/19 (0.0)1/19 (5.3)0/19 (0.0)1/19 (5.3)Same
88/95 (92.6)16/19 (84.2)19/19 (100.0)18/19 (94.7)19/19 (100.0)16/19 (84.2)Decrease
All (n=435)
17/435 (3.9)5/87 (5.7)0/87 (0.0)2/87 (2.3)0/87 (0.0)10/87 (11.5)Increase
19/435 (4.4)9/87 (10.3)0/87 (0.0)5/87 (5.7)0/87 (0.0)5/87 (5.7)Same
399/435 (91.7)73/87 (83.9)87/87 (100.0)80/87 (92.0)87/87 (100.0)72/87 (82.8)Decrease
aSDC: statistical disclosure control. Each of the 3 types of SDC applied (smoothing, unique removal and minimum leaf size for CART). SDC applied
to parametric and CART methods only. Smoothing applied to datasets with numeric attributes only. Minimum leaf size for CART is applicable to CART
only.




fSVM: support vector machine.
In most cases, the machine learning model accuracy decreases
when SDC measures are applied to the synthetic data used to
train the models. Decreases in accuracy are observed in all DT
and RF models and in 83% (72/87), 92% (80/87), and 84%
(73/87) of SGD, KNN, and SVM models, respectively. In a
small number of cases across SGD, KNN, and SVM models
trained on synthetic data with SDC measures applied, no change
or a slight increase in accuracy compared with models trained
on real data with no SDC measures applied was observed.
The mean absolute difference in accuracy when SDC measures
are applied to the training data (compared with machine learning
models trained on real data) is small across all machine learning
models and for all SDC techniques (Table 8). DT and RF models
have the largest difference in accuracy, consistent with earlier
results of these models trained on synthetic data with no SDC
measures applied. The accuracy decreases are consistent across
each SDC measure with no SDC measure affecting data utility
more notably than any other. These results are also illustrated
in the boxplots in Figure 5. Precision, recall, and F1 scores are
also consistent with earlier results when no SDC measures are
applied. We therefore consider that the SDC techniques
investigated do not have a notable impact on data utility beyond
what the standard synthesizers have.
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Table 8. Mean absolute difference in accuracy for each machine learning model and statistical disclosure control type.
Average change in accuracy per machine learning algorithmSDCa applied to synthetic dataset
SVMfRFeKNNdDTcSGDb
0.060 (6.0)0.177 (17.7)0.094 (9.4)0.190 (19.0)0.059 (5.9)Smoothing
0.056 (5.6)0.184 (18.4)0.072 (7.2)0.206 (20.6)0.052 (5.2)Unique removal
0.053 (5.3)0.180 (18.0)0.068 (6.8)0.200 (20.0)0.061 (6.1)Minimum leaf size
0.057 (5.7)0.180 (18.0)0.078 (7.8)0.199 (19.9)0.056 (5.6)All
aSDC: statistical disclosure control.




fSVM: support vector machine.
Figure 5. Overall change in accuracy for each machine learning model when trained on synthetic data across 19 datasets and 2 synthetic data approaches
(classification and regression tree [CART] and parametric) and with statistical disclosure control measures applied where smoothing (a; numeric attributes
only), unique removal (b), minimum leaf size constrained (c; for CART synthesizer only), and all approaches combined (d), compared with models
trained using real data.
We also compare the winning classifier when trained on real
data with the winning classifier when trained on synthetic data
with SDC applied (Table 9). The winning classifier when trained
on synthetic data with SDC applied matches the winning
classifier when trained on synthetic data in only 25% (22/87)
of cases, consistent with earlier results when SDC measures are
not applied. Similar results are observed when each SDC
measure is considered individually with the winning classifier
matching in models trained with real data compared with models
trained using synthetic data with SDC measures of smoothing,
unique removal, and minimum leaf size in 27% (8/30), 24%
(9/38), and 26% (5/19) of cases, respectively.
Consistent with results in the previous section where SDC
measures were not applied, removing tree-based classifiers (DT
and RF) from the analysis increases the matches in winning
classifiers trained on real compared with synthetic data by 13.3,
36.8, and 36.9 percentage points for each of the SDC measures
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of smoothing, unique removal, and minimum leaf size,
respectively. Overall, an increase of 28.7 percentage points is
observed for all SDC measures when tree-based classifiers are
removed.
Table 9. Number of instances where the winning classifier trained on synthetic data with statistical disclosure control applied matches the winning
classifier trained on real data across 19 datasets.
Winning classifier matches for real versus syntheticSynthetic dataset
3 classifiers (DT and RFb removed), n (%)4 classifiers (DTa removed), n (%)5 classifiers, n (%)
12/30 (40)14/30 (47)8/30 (27)Smoothing
23/38 (61)15/38 (40)9/38 (24)Unique removal
12/19 (63)7/19 (37)5/19 (26)Minimum leaf size
47/87 (54)36/87 (41)22/87 (25)All
aDT: decision tree.
bRF: random forest.
A chi-square test is applied with the following null and
alternative hypotheses:
• H0: the number of winning classifier matches is equal across
all sets of classifiers where SDC measures are applied.
• H1: the number of winning classifier matches increases
when DT and RF classifiers are removed where SDC
measures are applied.
The level of significance adopted for hypothesis testing is .05
for all tests performed (α=.05).
The null hypothesis is rejected when the tree-based models (DTs
and RFs) are removed (ie, from 5 to 3 classifiers) for data
synthesized with the SDC measure of unique removal applied
(Table 10). Therefore, a significant difference in the matching
winning classifiers is observed when tree-based classifiers are
removed for this SDC measure. The null hypothesis could not
be rejected in all other cases.
Table 10. Results of chi-square analysis of the difference in matching winning classifiers for models trained on real versus synthetic data with statistical
disclosure control applied.
P valuesSynthetic dataset








The need for synthetic data, particularly in the health care
domain, is gaining increasing attention as privacy protection
mechanisms are increasingly failing to protect modern data.
Due to valid privacy concerns, it is often difficult or impossible
to release real health care data thus impeding critical machine
learning research that can make use of this data to drive
improved patient outcomes and health policy decision-making.
Synthetic data has the potential to overcome data availability
issues, providing a valid alternative to real data. A small number
of synthetic data generators have been proposed in the literature;
however, evidence of their efficacy across a large number of
datasets and for use in machine learning is thin on the ground.
This work has explored the use of fully synthetic data across
19 health care datasets. Three well-known synthetic data
generators have been considered where data is generated using
CART, parametric, and Bayesian network techniques. A number
of research questions have been answered.
What Is the Differential in Performance When Using
Synthetic Data Versus Real Data for Training and
Testing Supervised Machine Learning Models?
Compared with models trained and tested on real data, almost
all machine learning models have a slightly lower accuracy
when trained on synthetic data and tested on real data across all
synthesizers and for all machine learning models analyzed;
however, the average decrease in accuracy was small in all
cases. Although still small, DT and RF models had a larger
decrease and variance in accuracy than SGD, KNN, and SVM
models. In addition to accuracy, an analysis of precision, recall,
and F1 scores also showed decreases in scores in models trained
with synthetic data, with Bayesian network-generated data
resulting in more variance than data generated using CART and
parametric techniques.
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What Is the Variance of Absolute Difference of
Accuracies Between Machine Learning Models Training
on Real and Synthetic Datasets?
The mean absolute difference was consistently small across all
models and synthetic datasets suggesting that these values could
provide a reliable indicator of the expected decrease in accuracy
in supervised machine learning models when developed using
synthetic data. Health care departments could expect a
manageable small yet consistent decrease in accuracy between
real and synthetic data.
How Often Does the Winning Machine Learning
Technique Change When Training Using Real Data to
Training Using Synthetic Data?
The winning classifier when trained on synthetic data matched
the winning classifier when trained on synthetic data in only
26% of cases for synthetic data generated using the CART and
parametric methods and in just 21% of cases on data synthesized
using the Bayesian network technique across the five machine
learning models considered (SGD, DT, KNN, RF, and SVM).
Tree-based methods were typically the winning classifier for
models trained on real data; however, this was often not the
case for models trained on synthetic data. When tree-based
models were not considered, the winning classifier when trained
on real data matched the winning classifier when trained on
synthetic data in 74%, 53%, and 68% of cases for synthetic data
generated using the CART, parametric, and Bayesian network
approaches, respectively. It would appear that tree-based
classifiers have some sensitivity to synthetic data, and the
underlying cause requires further investigation.
What Is the Impact of Statistical Disclosure Control (ie,
Privacy Protection) Measures on the Utility of Synthetic
Data (ie, Similarity to Real Data)?
The average change in accuracy when SDC measures are applied
to the training data was small across all machine learning models
and for all SDC techniques. Again, tree-based models produced
the largest decrease in accuracy across all SDC techniques. This
is attributed to the synthetic data generation method and not the
SDC measures, in line with previous results where SDC
measures were not applied. We therefore conclude that the SDC
techniques considered do not have a notable impact on data
utility beyond what the synthetic data generation methods alone
produce.
Limitations
This work has considered the impact of synthetic data on data
utility when the data are used to train supervised machine
learning algorithms. Further investigation with a broader range
of machine learning algorithms, supervised and unsupervised,
and including hyperparameter optimization is required. Such
studies should cover an even larger range of datasets including,
if possible, real health care department case studies.
Disclosure risk must also be explored in more detail. The impact
of SDC measures on data utility has been considered in this
work. Disclosure risk must also be measured across synthetic
datasets, and a comparison of the data utility and disclosure risk
trade-off should be performed.
Policy and Practice Implications
A wealth of rich health care data exists with the potential to
provide new insights for the prevention of diseases, development
of personalized medicine, and support of healthy life across the
population. These data are held by health care data gatekeepers
(eg, national health care departments) and are generally
prevented from release, even for research purposes, due to
justifiable privacy concerns around the protection of personal
data, ethics, and in guaranteeing citizens’ fundamental rights
and freedoms.
Data sharing and data use demand careful governance, with
legislation such as General Data Protection Regulation and the
EU-US Privacy Shield placing increasingly stringent guidelines
on data management. Data gatekeepers must manage myriad
issues in relation to the nature of the data (eg, categories of
sensitive data) and descriptions of the technical characteristics
of processed data, as well as sharing and management of the
data (eg, fair acquisition, data processing and data retention
policies, legal basis for information processing, appropriate
security measures) and the configuration of information systems
that store and process the data.
From a health care perspective, a range of technical solutions
using state-of-the-art machine learning could be developed using
health care data with the potential to derive knowledge that can
inform and enhance health care policy decision making and risk
stratification [36,48]. Such tools can have a positive impact on
health policy and practice, meeting the aims of national health
departments, for example, as stated by the Department of Health
Permanent Secretary in Northern Ireland, Richard Pengelly, in
support of the MIDAS project, “the Department seeks to
improve the health and social wellbeing of the people of NI,
reduce health inequalities, and to assure the provision of
appropriate health and social care services in clinical settings
and in the community.”
Accessing health care data to develop such tools is complex,
involving a lengthy legal and ethical process, and in some cases
access is impossible. Synthetic data can potentially overcome
the barriers to accessing data and the need for compliance with
data protection legislation as they infringe no privacy or
confidentiality while remaining durable, reusable, shareable,
clean, and potentially reliable as highlighted by Floridi [49],
thus accelerating the development of machine learning to inform
health care policy. Synthetic data also provide the opportunity
to democratize the application of machine learning to health
data for the benefit of patients and citizens enabling a larger
community to leverage the power of machine learning in health
care.
There is an increasing need for the development and evaluation
of a robust and trustworthy synthetic data generator. Policy
makers and clinicians who base decisions on models developed
with synthetic datasets must be able to do so with the assurance
that any knowledge elicited is very likely to be reflected in the
real data. Using synthetic datasets to facilitate machine learning
without disclosing sensitive data has the potential to
revolutionize health care research and policy making in an
impactful way by unlocking key research data in a secure way
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that could drive improvements in population health and
well-being much more quickly than is currently observed.
Conclusions
This work considers the efficacy of synthetic data for training
supervised machine learning models for use by health care
departments. The results are promising with small decreases in
accuracy observed in models trained with synthetic data
compared with those trained using real data. This work will be
further extended to assist in the development of standard
baselines for health care departments when using synthetic data
(eg, an expected and acceptable decrease in accuracy) and
synthetic data generators that can be trusted to produce the same
winning model as that which would be produced by real data.
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CART: classification and regression tree
DT: decision tree
KNN: k-nearest neighbors
MIDAS: Meaningful Integration of Data, Analytics, and Services
RF: random forest
SDC: statistical disclosure control
SGD: stochastic gradient descent
SVM: support vector machine
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